CircPTCH1 Promotes Migration in Lung Cancer by Regulating MYCN Expression Through miR-34c-5p

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Sun J, Xie T, Jamal M, et al. CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment. Cancer Cell Int. 2020;20:106. doi:10.1186/s12935-020-01183-1
   PubMed Web of Science ®Google Scholar
• Ma C, Yang X, Xing W, et al. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples. Thorac Cancer. 2020;11(3):588–593. doi:10.1111/1759-7714.13300
   PubMed Web of Science ®Google Scholar
• Du YX, Guo LX, Pan HS, et al. Circ_ANKIB1 stabilizes the regulation of miR-19b on SOCS3/STAT3 pathway to promote osteosarcoma cell growth and invasion. Hum Cell. 2020;33(1):252–260. doi:10.1007/s13577-019-00298-6
   PubMed Web of Science ®Google Scholar
• Aishanjiang K, Wei XD, Fu Y, et al. Circular RNAs and hepatocellular carcinoma: new epigenetic players with diagnostic and prognostic roles. Front Oncol. 2021;11:653717. doi:10.3389/fonc.2021.653717
   PubMed Web of Science ®Google Scholar
• Li Y, Feng W, Kong M, et al. Exosomal circRNAs: a new star in cancer. Life Sci. 2021;269:119039. doi:10.1016/j.lfs.2021.119039
   PubMed Web of Science ®Google Scholar
• Fu L, Tang D, Sun A, et al. Recent progress in study of circRNAs and its role in leukemia. J Leukoc Biol. 2021;109(4):731–739. doi:10.1002/JLB.2RU0619-213R
   PubMed Web of Science ®Google Scholar
• Xu Z, Xiang W, Chen W, et al. Circ-IGF1R inhibits cell invasion and migration in non-small cell lung cancer. Thorac Cancer. 2020;11(4):875–887. doi:10.1111/1759-7714.13329
   PubMed Web of Science ®Google Scholar
• Zhang CC, Li Y, Feng XZ, et al. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression. Bioengineered. 2021;12(1):414–425.
   PubMed Web of Science ®Google Scholar
• Gao W, Guo H, Niu M, et al. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Mol Cancer. 2020;19(1):166. doi:10.1186/s12943-020-01279-2
   PubMed Web of Science ®Google Scholar
• Shang A, Gu C, Wang W, et al. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-beta1 axis. Mol Cancer. 2020;19(1):117. doi:10.1186/s12943-020-01235-0
   PubMed Web of Science ®Google Scholar
• Jiao J, Zhang T, Jiao X, et al. hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion. J Cell Physiol. 2020;235(2):1287–1295. doi:10.1002/jcp.29045
   PubMed Web of Science ®Google Scholar
• Bhat AA, Younes SN, Raza SS, et al. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Mol Cancer. 2020;19(1):57.
   PubMed Web of Science ®Google Scholar
• Wang C, Fen Y, Li B, et al. CircRNAsin lung-intestinal axis cancer. Curr Mol Med. 2020;11:2479.
   Google Scholar
• Gao P, Wang Z, Hu Z, et al. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation. J Cell Biochem. 2020;121(3):2632–2642. doi:10.1002/jcb.29484
   PubMed Web of Science ®Google Scholar
• Ashrafizadeh M, Zarrabi A, Hushmandi K, et al. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: role of microRNAs and upstream mediators. Cell Signal. 2021;78:109871.
   PubMed Web of Science ®Google Scholar
• Liu H, Hu G, Wang Z, et al. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis. Theranostics. 2020;10(23):10791–10807. doi:10.7150/thno.47239
   PubMed Web of Science ®Google Scholar
• Lu Y, Ma T, Wang L, et al. [Advances in lymph node metastasis and lymph node dissection in early non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi. 2019;22(8):520–525. [Portuguese]
   PubMedGoogle Scholar
• Mott TF. Lung cancer: management. FP Essent. 2018;464:27–30.
   PubMedGoogle Scholar
• Huang W, Yan Y, Liu Y, et al. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin alpha2beta1. Signal Transduct Target Ther. 2020;5(1):39. doi:10.1038/s41392-020-0133-y
   PubMed Web of Science ®Google Scholar
• Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22–36. doi:10.1038/s41568-020-00306-0
   PubMed Web of Science ®Google Scholar
• Ma LL, Liang L, Zhou D, et al. Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4. Neoplasma. 2021;68(1):165–173. doi:10.4149/neo_2020_200707N705
   PubMed Web of Science ®Google Scholar
• Wu Z, Wu Y, Tian Y, et al. Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells. Oncol Lett. 2013;6(5):1447–1452. doi:10.3892/ol.2013.1579
   PubMed Web of Science ®Google Scholar
• Luo Y, Wang D, Chen S, et al. The role of miR-34c-5p/Notch in epithelial-mesenchymal transition (EMT) in endometriosis. Cell Signal. 2020;72:109666. doi:10.1016/j.cellsig.2020.109666
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang X, Tang J, et al. The study of mechanism of miR-34c-5p targeting FLOT2 to regulate proliferation, migration and invasion of osteosarcoma cells. Artif Cells Nanomed Biotechnol. 2019;47(1):3559–3568. doi:10.1080/21691401.2019.1640714
   PubMed Web of Science ®Google Scholar
• Xu X, Yan H, Zhang L, et al. Up-regulation of miR-34c-5p inhibits nasopharyngeal carcinoma cells by mediating NOTCH1. Biosci Rep. 2020;40:6. doi:10.1042/BSR20200302
   Web of Science ®Google Scholar
• Fereshteh Z, Schmidt SA, Al-Dossary AA, et al. Murine Oviductosomes (OVS) microRNA profiling during the estrous cycle: delivery of OVS-borne microRNAs to sperm where miR-34c-5p localizes at the centrosome. Sci Rep. 2018;8(1):16094. doi:10.1038/s41598-018-34409-4
   PubMedGoogle Scholar
• Wan Y, Shen A, Qi F, et al. Pien Tze Huang inhibits the proliferation of colorectal cancer cells by increasing the expression of miR-34c-5p. Exp Ther Med. 2017;14(4):3901–3907. doi:10.3892/etm.2017.4972
   PubMed Web of Science ®Google Scholar
• Li F, Chen H, Huang Y, et al. miR-34c plays a role of tumor suppressor in HEC1-B cells by targeting E2F3 protein. Oncol Rep. 2015;33(6):3069–3074. doi:10.3892/or.2015.3894
   PubMed Web of Science ®Google Scholar
• Tu Y, Hu Y. MiRNA-34c-5p protects against cerebral ischemia/reperfusion injury: involvement of anti-apoptotic and anti-inflammatory activities. Metab Brain Dis. 2021;36(6):1341–1351. doi:10.1007/s11011-021-00724-5
   PubMed Web of Science ®Google Scholar
• Liu B, Gan W, Jin Z, et al. The role of miR-34c-5p in osteogenic differentiation of bone marrow mesenchymal stem cells. Int J Stem Cells. 2021. doi:10.15283/ijsc20188
   Web of Science ®Google Scholar
• Cai H, Yu Y, Ni X, et al. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis. Cell Death Dis. 2020;11(12):1032. doi:10.1038/s41419-020-03247-6
   PubMed Web of Science ®Google Scholar
• Kong D, Fan S, Sun L, et al. Growth inhibition and suppression of the mTOR and Wnt/beta-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion. Hematol Oncol. 2021;39(2):222–230.
   PubMed Web of Science ®Google Scholar
• Lu Y, Yang Q, Su Y, et al. MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma. Cell Death Dis. 2021;12(6):511. doi:10.1038/s41419-021-03790-w
   PubMed Web of Science ®Google Scholar
• Wu X, Nelson M, Basu M, et al. MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination. J Immunother Cancer. 2021;9(3). doi:10.1136/jitc-2020-001388.
   Web of Science ®Google Scholar
• Irtan S, Brisse HJ, Minard-Colin V, et al. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection. Pediatr Blood Cancer. 2015;62(9):1543–1549. doi:10.1002/pbc.25511
   PubMed Web of Science ®Google Scholar
• Lee JK, Phillips JW, Smith BA, et al. N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells. Cancer Cell. 2016;29(4):536–547. doi:10.1016/j.ccell.2016.03.001
   PubMed Web of Science ®Google Scholar
• Berger A, Brady NJ, Bareja R, et al. N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer. J Clin Invest. 2019;129(9):3924–3940. doi:10.1172/JCI127961
   PubMed Web of Science ®Google Scholar
• Grunblatt E, Wu N, Zhang H, et al. MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity. Genes Dev. 2020;34(17–18):1210–1226. doi:10.1101/gad.340133.120
   PubMed Web of Science ®Google Scholar
• Liu K, Wang S, Liu Y, et al. Overexpression of MYCN promotes proliferation of non-small cell lung cancer. Tumour Biol. 2016;37(9):12855–12866. doi:10.1007/s13277-016-5236-2
   PubMedGoogle Scholar